Bortezomib in Combination with Physachenolide C Reduces the Tumorigenic Properties of KRASmut/P53mut Lung Cancer Cells by Inhibiting c-FLIP is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health (NIH)
Grant: U54 MD007593
National Institutes of Health (NIH)
Grant: U54 CA163069
National Institutes of Health (NIH)
Grant: SC1 CA182843
NIMHD NIH HHS
Grant: S21 MD000104
NIMHD NIH HHS
Grant: U54 MD007586
National Institutes of Health
Grant: 5U54MD007593-09
Meharry Clinical and Translational Research Center (MeTRC)
National Institutes of Health
Grant: 5U54CA163069-05
Development: Cancer Outreach Core
National Institutes of Health
Grant: 1SC1CA182843-01A1
Defining the effects of bortezomib on NK cell activation in cancer
American Cancer Society (ACS)
Fields of Study
Keywords
Sustainable Development Goals